Economic Evaluation of a Novel Lung Cancer Diagnostic in a Population of Patients with a Positive Low-Dose Computed Tomography Result
**Background:** Early detection of lung cancer is crucial for improving patient outcomes. Although advances in diagnostic technologies have significantly enhanced the ability to identify lung cancer in earlier stages, there are still limitations. The alarming rate of false positives has resulted in...
Saved in:
Main Authors: | Michael J. Morris, Sheila A. Habib, Maggie L. Do Valle, John E. Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.121512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality of computed tomography image versus dose in hybrid studies: preliminary results in phantom
by: Adlin López Díaz, et al.
Published: (2022-03-01) -
Comparison on diagnostic results of clinical, radiological and computed tomography of stifle joint in dogs
by: Nil Aracı, et al. -
Effective Dose Estimation in Computed Tomography by Machine Learning
by: Matteo Ferrante, et al.
Published: (2025-01-01) -
Enhancing Diagnostic Accuracy of Lung Nodules in Chest Computed Tomography Using Artificial Intelligence: Retrospective Analysis
by: Weiqi Liu, et al.
Published: (2025-01-01) -
Modeling dose uncertainty in cone-beam computed tomography: Predictive approach for deep learning-based synthetic computed tomography generation
by: Cédric Hémon, et al.
Published: (2025-01-01)